MAP2 and Parkinson disease: PEA protected from the decrease in MAP-2 expression induced by amyloid peptides (Scuderi et al., 2014; Tomasini et al., 2015) and by MPTP in an animal model of Parkinson’s disease (Esposito et al., 2012).